×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Program Committee
-
Vicki Edwards, RPh Vice President, Pharmacovigilance Excellence and International QPPV
Abbvie, United Kingdom -
Willemijn van der Spuij, MSc Executive Director, WorldWide Patient Safety International, Europe
Switzerland -
Shahinaz Badr Pharmacovigilance Consultant and PVQA Auditor - EMEA
Pharma Quality Europe, United Arab Emirates -
Peter De Veene, MD GQPPV
MSD Belgium, Belgium -
Gemma Jimenez Sese Senior Director, Deputy EU QPPV
AstraZeneca, Spain -
Maarten Lagendijk, MSc Deputy EU QPPV
MSD, Netherlands -
Elspeth McIntosh, MBA, RN Director
Castle Pharmacovigilance Ltd, United Kingdom -
Mette Stockner, MD Senior Pharmacovigilance Director
Savara ApS, Denmark -
Doris Irene Stenver, MD, MPA Independent Pharmacovigilance Adviser
Unique Advice, Denmark -
Katarzyna Swiderek, MPharm, RPh Director, Safety Evaluation Risk Management (SERM)
GlaxoSmithKline, Poland -
Kiernan Trevett, MSc Quality Policy Lead
Genentech, A Member of the Roche Group, United States -
Nicolas Tsiakkas, MD Scientific Director
NIKOLAS TSIAKKAS AND CO OE, Greece -
Angela Van Der Salm, PhD, MSc Director PV, Managing partner
DADA Consultancy B.V., Netherlands -
Magnus Ysander, MD EU & UK QPPV & Head Pharmacovigilance Excellence
AstraZeneca, Sweden
Have an account?